SynthesisFrontiers in physiology2026
P INK1/PARKIN mitophagy: a potential regulator of mitochondrial homeostasis in functional dyspepsia.
Synthesis in Frontiers in physiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Functional dyspepsia (FD) is a highly prevalent functional gastrointestinal disorder with limited long-term treatment efficacy and high recurrence rates, while its upstream pathogenic mechanisms remain incompletely defined. Mitochondrial dysfunction and defective mitophagy represent key pathological events underlying FD pathogenesis. Beyond the PINK1/PARKIN-dependent ubiquitinated mitophagy cascade, the non-ubiquitin BNIP3/NIX mitophagy axis also mediates gastrointestinal mitochondrial quality control under hypoxic and inflammatory stimuli. As the canonical signaling pathway governing mitophagy and mitochondrial homeostasis, the PINK1/PARKIN axis potentially participates in regulating gastrointestinal energy metabolism, restraining oxidative stress, modulating visceral sensation, and maintaining mucosal barrier integrity. This narrative review elaborates the molecular regulatory mechanisms of the PINK1/PARKIN pathway and proposes a tentative pathological cascade: impaired PINK1/PARKIN signaling - defective mitophagy - gastrointestinal dysmotility, visceral hypersensitivity and chronic low-grade inflammation - FD onset and progression. We further summarize prominent unresolved research gaps in this field. Further investigations targeting this pathway may offer novel theoretical foundations and promising intervention targets for precision diagnosis and management of FD.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.